Telavant Holdings

  • Roche to pay $7.1 bn for Telavant Holdings

    by - Oct 24, 2023
    On Monday, the Swiss pharmaceutical company Roche announced that it will acquire Telavant Holdings, a company that is creating novel treatments for inflammatory bowel disorders, for $7.1 billion. Currently, American pharmaceutical behemoth Pfizer and British laboratory...
Contact News Hour

Facebook

Twitter